MedPath

Study conducted to see the effect of Vasadi Kwath with Erand Tail in symptoms of Vatarakta

Phase 1
Conditions
Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissueHealth Condition 2: M109- Gout, unspecifiedHealth Condition 3: M20-M25- Other joint disorders
Registration Number
CTRI/2020/11/029039
Lead Sponsor
Sima Balaprasad Jaju
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age limit from 20 to 70 years.

Patients having clinical symptoms of Vatarakta like Pain in joints, Swelling, burning, Tenderness at joints.

Exclusion Criteria

Patient with severe form of other systemic disorders like Cardiac disease, renal failure, CVA etc will be excluded.

Pregnant women and lactating mothers.

Injury requiring surgical interventions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To achieve marked relief in signs and symptoms of vataraktaTimepoint: The cure shall be assessed in 3 follow up(0,7th,15th,30th)30 days.
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath